Tumor microbiome diversity influences papillary thyroid cancer invasion/Experiment 24
From BugSigDB
Reviewed Marked as Reviewed by Svetlana up on 2025-1-13
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Thyroid gland Glandula thyroidea,Thyroid,Thyroid gland,thyroid gland
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Papillary thyroid carcinoma papillary cancer of the thyroid,papillary cancer of the thyroid gland,papillary cancer of thyroid,papillary cancer of thyroid gland,papillary carcinoma of the thyroid,papillary carcinoma of the thyroid gland,papillary carcinoma of thyroid,papillary carcinoma of thyroid gland,papillary thyroid cancer,papillary thyroid carcinoma,papillary thyroid gland carcinoma,thyroid gland papillary cancer,thyroid gland papillary carcinoma,thyroid papillary carcinoma,Papillary thyroid carcinoma
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Patients with PTC at clinical stage T1
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Patients with PTC at clinical stage T4
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Papillary thyroid cancer (PTC) at clinical stage T4.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 35
- Group 1 sample size Number of subjects in the case (exposed) group
- 6
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- Kruskall-Wallis
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
- Richness Number of species
- unchanged
Signature 1
Reviewed Marked as Reviewed by Svetlana up on 2025-1-13
Source: Supplementary Data 4 (Sheet 2)
Description: Microbiome alterations at the genus level in patients with PTC of clinical stages T1–T4.
Abundance in Group 1: decreased abundance in Patients with PTC at clinical stage T4
Revision editor(s): Aleru Divine, WikiWorks
Signature 2
Reviewed Marked as Reviewed by Svetlana up on 2025-1-13
Source: Supplementary Data 4 (Sheet 2)
Description: Microbiome alterations at the genus level in patients with PTC of clinical stages T1–T4.
Abundance in Group 1: increased abundance in Patients with PTC at clinical stage T4
Revision editor(s): Aleru Divine, WikiWorks
